AAMU
MED icon

Amundi Asset Management US’s Medifast MED Stock Holding History

Amundi Asset Management US’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$10.2M Buy
48,146
+7,318
+18% +$1.75M 0.01% 835
2020
Q4 		$8.02M Sell
40,828
-1,324
-3% -$234K 0.01% 862
2020
Q3 		$6.93M Sell
42,152
-28,557
-40% -$4.7M 0.01% 816
2020
Q2 		$9.81M Buy
70,709
+8,043
+13% +$738K 0.01% 715
2020
Q1 		$1.27M Buy
+62,666
New +$5.71M ﹤0.01% 1052
2019
Q4 		– Sell
-58,576
Closed -$6.07M – 1644
2019
Q3 		$6.07M Buy
58,576
+15,114
+35% +$1.62M 0.01% 815
2019
Q2 		$41.1M Sell
43,462
-1,688
-4% -$234K 0.03% 372
2019
Q1 		$5.76M Buy
45,150
+10,792
+31% +$1.37M 0.01% 857
2018
Q4 		$4.29M Buy
34,358
+2,476
+8% +$424K ﹤0.01% 864
2018
Q3 		$7.06M Sell
31,882
-3,250
-9% -$659K 0.01% 817
2018
Q2 		$5.63M Buy
+35,132
New +$4.49M 0.01% 882

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Amundi Asset Management US's MED Position: Q1 2021 in Review

Amundi Asset Management US increased its Medifast (MED) stake by 18% in Q1 2021, buying an estimated $1.75M and bringing the position to 48,146 shares worth $10.2M. The position accounts for 0.01% of the portfolio, ranked #835.

Amundi Asset Management US first reported a position in MED in Q2 2018 and has held it in 11 quarters since. The position peaked at $41.1M in Q2 2019. 277 funds tracked by Wall St. Rank hold MED as of Q1 2021.

  • Amundi Asset Management US held 48,146 shares of Medifast worth $10.2M as of Q1 2021.
  • Amundi Asset Management US bought 7,318 Medifast shares in Q1 2021, an estimated $1.75M.
  • Medifast made up 0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #835 holding.
  • Amundi Asset Management US first reported a position in Medifast in Q2 2018 and has held it in 11 quarters since.
  • Amundi Asset Management US's Medifast position peaked at $41.1M in Q2 2019.
  • 277 funds tracked by Wall St. Rank held Medifast as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.